Bayer Aktiengesellschaft (BAYRY)

Healthcare
Drug Manufacturers - General
Germany
Yahoo Finance  •  Trading View  •  Company site
Price
$13.67
▲ 0.05 (0.37%)
Market Cap
$55,430,221,824
Shares: 3,929,696,328
P/E
N/A
P/B: N/A
ROE
N/A
Current Ratio: N/A
Fundamentals Score
0 (NEGATIVE)

Company Overview

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, pain and cardiovascular risk prevention products, digestive health products, allergy products, and cold and cough products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Headquarters: Kaiser-Wilhelm-Allee 1, Leverkusen, 51368, Germany  |  Employees: 88502  |  Website: bayer.com
Key Contacts
IR / Phone: 49 214 30 1
Exchange: OQX
Industry: Drug Manufacturers - General
Quick Financial Snapshot
RevenueN/A
Net IncomeN/A
Free Cash FlowN/A
Book Value / ShareN/A

Balance Sheet & Liquidity

Total LiabilitiesN/A
Total EquityN/A
Debt / EquityN/A
Current RatioN/A
Interest CoverageN/A
Working CapitalN/A

Valuation Metrics

Core multiples and valuation signals — useful to compare vs peers.

P/E (TTM)N/A
Industry P/EN/A
Forward P/E9.38
P/BN/A
Price / SalesN/A
P / FCFN/A
EV / EBITDAN/A
Graham NumberN/A
DCF (placeholder)
Notes: red items typically indicate expensive multiples relative to fundamentals. Use the "Compare with industry" tool for context.

EPS (Annual)

Financial Performance

Revenue vs Net Income

Free Cash Flow (annual)

Profitability & Efficiency

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROIC N/A
Asset Turnover N/A

Automated Fundamental Signals (Score: 0)

Passed
  • No passed rules available
Failed
  • Price CAGR -6.29%
  • Positive Free Cash Flow
  • DCF valuation (undefined)

Price Chart (Candlestick)

Technical Analysis (Score: 75)

RSI (14)66.91
SMA 5011.61
SMA 2008.73
MACD0.62
Signal BULLISH
RSI 66.9, SMA trend bullish, momentum 149.9%.

Governance & Management

Governance scores: Audit: N/A | Board: N/A | Compensation: N/A | Shareholder Rights: N/A
Executive Team
NameTitle
Mr. William N. Anderson Chairman of the Management Board & CEO (1966)
Mr. Wolfgang U. Nickl CFO & Member of Management Board (1969)
Mr. Stefan Oelrich Head of the Pharmaceuticals Division & Member of the Board of Management (1968)
Mr. Rodrigo Santos Member of Management Board & President of the Crop Science Division (1973)
Ms. Heike Prinz Chief Talent Officer, Labor Director & Member of Management Board (1964)
Mr. Julio Triana Member of Management Board & President of Consumer Health Division (1965)
Dr. Sebastian Guth Ph.D. COO & Head of Commercial Operations Americas of Pharmaceutical (—)
Ms. Amanda McClerren Chief Information Officer, Head-Digital Transformation & IT-Crop Science Division (—)
Governance data last updated: N/A

Latest News

No news available for this company.

← Back